 | Up a level |
Weis, C; Blank, Fabian; West, A; Black, G; Woodward, RC; Carroll, MR; Mainka, A; Kartmann, R; Brandl, A; Bruns, H; Hallam, E; Shaw, J; Murphy, J; Teoh, WY; Aifantis, KE; Amal, R; House, M; Pierre, TS; Fabry, B (2013). Labeling of cancer cells with magnetic nanoparticles for magnetic resonance imaging. Magnetic resonance in medicine, 71(5), pp. 1896-1905. Wiley-Liss 10.1002/mrm.24832
Marre, M; Shaw, J; Brändle, M; Bebakar, WM; Kamaruddin, NA; Strand, J; Zdravkovic, M; Le, Thi TD; Colagiuri, S; De Loredo, L; Waitman, J; Litwak, L; Rodriguez, M; Vines, G; Maffei, L; Issa, C; Lowy, A; Bartley, P; Kamp, M; Shaw, J; ... (2009). Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD-1 SU). Diabetic medicine, 2009(26(3)), pp. 268-78. Chichester: Wiley 10.1111/j.1464-5491.2009.02666.x
